U.S. Says It Need Not Produce Docs In AWP Case

Law360, New York (November 5, 2007, 12:00 AM EST) -- In a government action against the major drug companies over an alleged Medicare scam, the U.S. on Friday defended its right to keep secret records explaining the rationale for relying on the industry's own prices.

In October, drug manufacturer Abbott Laboratories Inc. urged the Massachusetts judge overseeing the multidistrict litigation over the industry's average wholesale drug prices to compel the government to turn over documents detailing its decision to adopt, and keep, the reported prices as the basis for Medicare rebates on prescription medication.

Abbott is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.